Geode Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.08M | Buy |
1,483,787
+40,822
| +3% | +$267K | ﹤0.01% | 2606 |
|
|
2026
Q1 | $9.97M | Buy |
1,442,965
+51,175
| +4% | +$395K | ﹤0.01% | 2381 |
|
|
2025
Q4 | $12.3M | Sell |
1,391,790
-295
| -0% | -$1.62K | ﹤0.01% | 2304 |
|
|
2025
Q3 | $6.95M | Sell |
1,392,085
-299,553
| -18% | -$1.39M | ﹤0.01% | 2617 |
|
|
2025
Q2 | $7.99M | Buy |
1,691,638
+77,997
| +5% | +$341K | ﹤0.01% | 2488 |
|
|
2025
Q1 | $7.41M | Buy |
1,613,641
+163,331
| +11% | +$761K | ﹤0.01% | 2463 |
|
|
2024
Q4 | $6.95M | Buy |
1,450,310
+24,483
| +2% | +$118K | ﹤0.01% | 2571 |
|
|
2024
Q3 | $6.69M | Buy |
1,425,827
+94,870
| +7% | +$509K | ﹤0.01% | 2599 |
|
|
2024
Q2 | $7.52M | Buy |
1,330,957
+85,575
| +7% | +$442K | ﹤0.01% | 2499 |
|
|
2024
Q1 | $5.12M | Sell |
1,245,382
-121
| -0% | -$484 | ﹤0.01% | 2692 |
|
|
2023
Q4 | $5.26M | Buy |
1,245,503
+66,248
| +6% | +$267K | ﹤0.01% | 2681 |
|
|
2023
Q3 | $5.1M | Buy |
1,179,255
+44,331
| +4% | +$246K | ﹤0.01% | 2631 |
|
|
2023
Q2 | $7.48M | Buy |
1,134,924
+52,393
| +5% | +$336K | ﹤0.01% | 2469 |
|
|
2023
Q1 | $7.35M | Buy |
1,082,531
+29,941
| +3% | +$211K | ﹤0.01% | 2446 |
|
|
2022
Q4 | $7.78M | Buy |
1,052,590
+26,077
| +3% | +$254K | ﹤0.01% | 2424 |
|
|
2022
Q3 | $10.1M | Buy |
1,026,513
+9,345
| +0.9% | +$98.7K | ﹤0.01% | 2247 |
|
|
2022
Q2 | $11.1M | Buy |
1,017,168
+4,727
| +0.5% | +$49K | ﹤0.01% | 2177 |
|
|
2022
Q1 | $11.4M | Sell |
1,012,441
-14,817
| -1% | -$195K | ﹤0.01% | 2262 |
|
|
2021
Q4 | $16.1M | Buy |
1,027,258
+16,554
| +2% | +$288K | ﹤0.01% | 2099 |
|
|
2021
Q3 | $17.3M | Buy |
1,010,704
+6,342
| +0.6% | +$111K | ﹤0.01% | 2054 |
|
|
2021
Q2 | $21.6M | Buy |
1,004,362
+38,948
| +4% | +$697K | ﹤0.01% | 1910 |
|
|
2021
Q1 | $14.5M | Buy |
965,414
+113,991
| +13% | +$1.85M | ﹤0.01% | 2089 |
|
|
2020
Q4 | $11.2M | Buy |
851,423
+33,581
| +4% | +$404K | ﹤0.01% | 2095 |
|
|
2020
Q3 | $7.9M | Buy |
817,842
+11,924
| +1% | +$127K | ﹤0.01% | 2111 |
|
|
2020
Q2 | $9.22M | Buy |
805,918
+43,693
| +6% | +$495K | ﹤0.01% | 1962 |
|
|
2020
Q1 | $7.9M | Buy |
762,225
+1,663
| +0.2% | +$20.6K | ﹤0.01% | 1885 |
|
|
2019
Q4 | $12.5M | Buy |
760,562
+3,323
| +0.4% | +$50.2K | ﹤0.01% | 1856 |
|
|
2019
Q3 | $10.1M | Buy |
757,239
+29,354
| +4% | +$409K | ﹤0.01% | 1933 |
|
|
2019
Q2 | $10.3M | Buy |
727,885
+88,791
| +14% | +$1.41M | ﹤0.01% | 1937 |
|
|
2019
Q1 | $11.8M | Buy |
639,094
+42,468
| +7% | +$968K | ﹤0.01% | 1790 |
|
|
2018
Q4 | $15.6M | Buy |
596,626
+6,666
| +1% | +$157K | ﹤0.01% | 1456 |
|
|
2018
Q3 | $13.5M | Buy |
589,960
+25,040
| +4% | +$511K | ﹤0.01% | 1703 |
|
|
2018
Q2 | $10.8M | Buy |
564,920
+63,774
| +13% | +$1.07M | ﹤0.01% | 1813 |
|
|
2018
Q1 | $8.44M | Buy |
501,146
+102,100
| +26% | +$1.71M | ﹤0.01% | 1887 |
|
|
2017
Q4 | $6.07M | Sell |
399,046
-26,998
| -6% | -$401K | ﹤0.01% | 2099 |
|
|
2017
Q3 | $7.63M | Sell |
426,044
-6,010
| -1% | -$101K | ﹤0.01% | 1934 |
|
|
2017
Q2 | $7.04M | Buy |
432,054
+19,530
| +5% | +$281K | ﹤0.01% | 1898 |
|
|
2017
Q1 | $5.78M | Buy |
412,524
+23,941
| +6% | +$341K | ﹤0.01% | 2004 |
|
|
2016
Q4 | $6.2M | Buy |
388,583
+16,274
| +4% | +$262K | ﹤0.01% | 1915 |
|
|
2016
Q3 | $6.2M | Buy |
372,309
+4,652
| +1% | +$62.6K | ﹤0.01% | 1828 |
|
|
2016
Q2 | $4.11M | Sell |
367,657
-12,014
| -3% | -$116K | ﹤0.01% | 2046 |
|
|
2016
Q1 | $3.17K | Buy |
379,671
+31,939
| +9% | +$262K | ﹤0.01% | 2155 |
|
|
2015
Q4 | $3.24M | Buy |
347,732
+66,261
| +24% | +$661K | ﹤0.01% | 2167 |
|
|
2015
Q3 | $3.17M | Sell |
281,471
-14,074
| -5% | -$172K | ﹤0.01% | 2138 |
|
|
2015
Q2 | $3.75M | Buy |
295,545
+71,473
| +32% | +$771K | ﹤0.01% | 2099 |
|
|
2015
Q1 | $2.08M | Buy |
224,072
+2,967
| +1% | +$33.5K | ﹤0.01% | 2413 |
|
|
2014
Q4 | $3.17M | Buy |
221,105
+27,365
| +14% | +$324K | ﹤0.01% | 2116 |
|
|
2014
Q3 | $2.01M | Buy |
193,740
+2,248
| +1% | +$29.5K | ﹤0.01% | 2358 |
|
|
2014
Q2 | $3.1M | Buy |
191,492
+1,563
| +0.8% | +$20.8K | ﹤0.01% | 2107 |
|
|
2014
Q1 | $3.09M | Buy |
189,929
+5,113
| +3% | +$72.7K | ﹤0.01% | 2075 |
|
|
2013
Q4 | $2.29M | Buy |
184,816
+4,751
| +3% | +$47.7K | ﹤0.01% | 2217 |
|
|
2013
Q3 | $1.98M | Buy |
180,065
+7,362
| +4% | +$78.7K | ﹤0.01% | 2177 |
|
|
2013
Q2 | $1.4M | Buy |
+172,703
| New | +$1.16M | ﹤0.01% | 2265 |
|
Other funds holding VNDA
ACM
Geode Capital Management's VNDA Position: Q2 2026 in Review
Geode Capital Management increased its Vanda Pharmaceuticals (VNDA) stake by 2.8% in Q2 2026, buying an estimated $267K and bringing the position to 1,483,787 shares worth $9.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2606.
Geode Capital Management first reported a position in VNDA in Q2 2013 and has held it in 53 quarters since. The position peaked at $21.6M in Q2 2021. 171 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.
- Geode Capital Management held 1,483,787 shares of Vanda Pharmaceuticals worth $9.08M as of Q2 2026.
- Geode Capital Management bought 40,822 Vanda Pharmaceuticals shares in Q2 2026, an estimated $267K.
- Vanda Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2606 holding.
- Geode Capital Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Vanda Pharmaceuticals position peaked at $21.6M in Q2 2021.
- 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.